Cargando…
APOBEC3A catalyzes mutation and drives carcinogenesis in vivo
The APOBEC3 family of antiviral DNA cytosine deaminases is implicated as the second largest source of mutation in cancer. This mutational process may be a causal driver or inconsequential passenger to the overall tumor phenotype. We show that human APOBEC3A expression in murine colon and liver tissu...
Autores principales: | Law, Emily K., Levin-Klein, Rena, Jarvis, Matthew C., Kim, Hyoung, Argyris, Prokopios P., Carpenter, Michael A., Starrett, Gabriel J., Temiz, Nuri A., Larson, Lindsay K., Durfee, Cameron, Burns, Michael B., Vogel, Rachel I., Stavrou, Spyridon, Aguilera, Alexya N., Wagner, Sandra, Largaespada, David A., Starr, Timothy K., Ross, Susan R., Harris, Reuben S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953736/ https://www.ncbi.nlm.nih.gov/pubmed/32870257 http://dx.doi.org/10.1084/jem.20200261 |
Ejemplares similares
-
DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo
por: Naumann, Jordan A., et al.
Publicado: (2023) -
Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B
por: Akre, Monica K., et al.
Publicado: (2016) -
Mutation Signatures Including APOBEC in Cancer Cell Lines
por: Jarvis, Matthew C, et al.
Publicado: (2018) -
Human APOBEC3B promotes tumor heterogeneity in vivo including signature mutations and metastases
por: Durfee, Cameron, et al.
Publicado: (2023) -
Human APOBEC3B promotes tumor development in vivo including signature mutations and metastases
por: Durfee, Cameron, et al.
Publicado: (2023)